Invesco S&P Smallcap Health Care Etf Newsroom

Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?

BenzingaDec 1 10:48 ET

RadNet Analyst Ratings

BenzingaNov 29 13:16 ET · Ratings

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaNov 29 12:35 ET

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

BenzingaNov 27 16:05 ET

Spotlight on Hims & Hers Health: Analyzing the Surge in Options Activity

BenzingaNov 27 15:36 ET

BTIG Maintains Buy on Glaukos, Raises Price Target to $149

BenzingaNov 26 12:09 ET · Ratings

Glaukos Analyst Ratings

BenzingaNov 26 12:07 ET · Ratings

What's Going On With Hims & Hers Health Stock Monday?

BenzingaNov 25 17:16 ET

Hims & Hers Health Trading 22% Higher, WIth Gains Attributed to FDA Nominee

BenzingaNov 25 15:04 ET

After Trump's nomination of the FDA director, the supplier of "affordable weight loss drugs" Hims & hers surged more than 20%, reaching a historic high.

"Affordable weight loss pharmaceutical" supplier Hims & hers once rose over 20%, reaching $30.57, surpassing the previous intraday record high of $30.44 set on November 13. The reason is that institutions Hunterbrook Media, who benchmark against short sellers Citron, believe that Trump's nomination of Marty Makary as the director of the usa Food and Drug Administration (FDA) could benefit Hims & hers.

wallstreetcnNov 25 14:39 ET

Hims & Hers up 18% Amid Optimism for Compounders With Makary FDA Pick

Seeking AlphaNov 25 12:46 ET

BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday

BenzingaNov 25 10:21 ET

Applied Digital And Hims & Hers Health Are Among Top 9 Mid-Cap Gainers Last Week (Nov 18-Nov 22): Are The Others In Your Portfolio?

BenzingaNov 24 10:20 ET

Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...

BenzingaNov 21 16:10 ET

Hims & Hers Closes up 10% as Lilly Tirzepatide Compounding Dispute Resolution Delayed

Seeking AlphaNov 21 16:09 ET

Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade

BenzingaNov 20 14:08 ET

Trump Media Saw the Largest Increase in Short Interest in October

Seeking AlphaNov 20 10:57 ET

TD Cowen Reiterates Buy on Hims & Hers Health, Maintains $28 Price Target

BenzingaNov 20 10:38 ET · Ratings

Inspire Medical Systems Analyst Ratings

BenzingaNov 20 07:39 ET · Ratings

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaNov 19 16:05 ET